Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Oncolytics Biotech Inc (TO: ONC)

 
ONC Technical Analysis
5
As on 1st Sep 2025 ONC STOCK Price closed @ 16.90 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.39 & Strong Buy for SHORT-TERM with Stoploss of 1.49 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ONCSTOCK Price

Open 16.90 Change Price %
High 16.90 1 Day 15.48 1090.14
Low 16.90 1 Week 15.56 1161.19
Close 16.90 1 Month 15.30 956.25
Volume 300 1 Year 15.47 1081.82
52 Week High 1.91 | 52 Week Low 0.45
 
TO Canada Most Active Stocks
YRI 7.89 0.13%
CNQ 43.08 -2.34%
UEX 0.50 16.28%
SU 56.12 -1.44%
BTE 3.10 -4.32%
ENB 66.68 0.18%
SJR-B 40.48 0.02%
MFC 42.07 0.12%
CVE 22.76 -2.74%
BTO 5.70 -2.73%
 
TO Canada Top Gainers Stocks
ONC 16.90 1090.14%
ONC 16.90 1090.14%
CUB 0.21 950.00%
CUB 0.21 950.00%
AOI 13.38 611.70%
AOI 13.38 611.70%
GGA 0.03 50.00%
MIN 0.20 42.86%
MIN 0.20 42.86%
MIN 0.20 42.86%
 
TO Canada Top Losers Stocks
MOZ 0.16 -80.25%
MOZ 0.16 -80.25%
EXRO 0.02 -60.00%
PPR 0.02 -33.33%
PPR 0.02 -33.33%
LEV 0.34 -29.17%
LEV 0.34 -29.17%
LEV 0.34 -29.17%
YRB 0.04 -20.00%
YRB 0.04 -20.00%
 
 
ONC
Daily Charts		 ONC
Intraday Charts		 Whats New @
Bazaartrend		 ONC
Free Analysis
 
ONC Important Levels Intraday
RESISTANCE16.90
RESISTANCE16.90
RESISTANCE16.90
RESISTANCE16.90
RESISTANCE16.90
RESISTANCE16.90
RESISTANCE16.90
RESISTANCE16.90
 
ONC Forecast September 2025
Share
4th UP Forecast17.73
3rd UP Forecast17.46
2nd UP Forecast17.3
1st UP Forecast17.13
1st DOWN Forecast16.67
2nd DOWN Forecast16.5
3rd DOWN Forecast16.34
4th DOWN Forecast16.07
 
ONC Weekly Forecast
4th UP Forecast17.11
3rd UP Forecast17.04
2nd UP Forecast17.00
1st UP Forecast16.96
1st DOWN Forecast16.84
2nd DOWN Forecast16.80
3rd DOWN Forecast16.76
4th DOWN Forecast16.69
 
ONC Forecast2025
4th UP Forecast48.62
3rd UP Forecast38.45
2nd UP Forecast32.16
1st UP Forecast25.87
1st DOWN Forecast7.93
2nd DOWN Forecast1.64
3rd DOWN Forecast-4.65
4th DOWN Forecast-14.82
 
 
ONC Other Details
Segment EQ
Market Capital 143444816.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ONC Address
ONC
 
ONC Latest News
 
Your Comments and Response on Oncolytics Biotech Inc
 
ONC Business Profile
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an immuno-oncology viral-agent for the treatment of solid tumors and hematological malignancies. The company has collaboration agreements with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone-receptor positive, human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada. Address: 1167 Kensington Crescent NW, Calgary, AB, Canada, T2N 1X7
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service